Cuicui Li

Notable Publications:

Yang Q, Chen Z, Qiu Y, Huang W, Wang T, Song L, Sun X, Li C, Xu X, Kang L. Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1246-1260. doi: 10.1007/s00259-023-06575-9. Epub 2023 Dec 23. Erratum in: Eur J Nucl Med Mol Imaging. 2024 Jan 12;: PMID: 38135849.

Yang Q, Huang W, Hsu JC, Song L, Sun X, Li C, Cai W, Kang L. CD146-targeted nuclear medicine imaging in cancer: state of the art. View (Beijing). 2023 Oct;4(5):20220085. doi: 10.1002/VIW.20220085. Epub 2023 Mar 1. PMID: 38076327; PMCID: PMC10703309.

Li C, Chen X, Zhang J. Comment on: "Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumors". J Pharm Anal. 2023 Sep;13(9):958-959. doi: 10.1016/j.jpha.2023.07.010. Epub 2023 Jul 20. PMID: 37842653; PMCID: PMC10568078.

Li C, Liu J, Yang X, Yang Q, Huang W, Zhang M, Zhou D, Wang R, Gong J, Miao Q, Kang L, Yang J. Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):168-183. doi: 10.1007/s00259-022-05954-y. Epub 2022 Sep 5. PMID: 36063202.

Li C, Yang Q, Chen Z, Qiu Y, Du Y, Wang R, He Q, Yang J, Zhen H, Kang L. Noninvasive Evaluation of Multidrug Resistance via Imaging of ABCG2/BCRP Multidrug Transporter in Lung Cancer Xenograft Models. Mol Pharm. 2022 Oct 3;19(10):3521-3529. doi: 10.1021/acs.molpharmaceut.1c00939. Epub 2022 Apr 15. PMID: 35427142.

Kang L, Li C, Yang Q, Sutherlin L, Wang L, Chen Z, Becker KV, Huo N, Qiu Y, Engle JW, Wang R, He C, Jiang D, Xu X, Cai W. 64Cu-labeled daratumumab F(ab')2 fragment enables early visualization of CD38-positive lymphoma. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1470-1481. doi: 10.1007/s00259-021-05593-9. Epub 2021 Oct 22. PMID: 34677626; PMCID: PMC8940612.

Li C, Yang X, Lu X, Wang W, Yang J. FDG PET/CT Demonstrated Epstein-Barr Virus-Associated Leiomyosarcoma in a Pediatric Patient With Wiskott-Aldrich Syndrome. Clin Nucl Med. 2022 Feb 1;47(2):190-191. doi: 10.1097/RLU.0000000000004020. PMID: 35006111.

Li C, Kang L, Fan K, Ferreira CA, Becker KV, Huo N, Liu H, Yang Y, Engle JW, Wang R, Xu X, Jiang D, Cai W. ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models. Bioconjug Chem. 2021 Jul 21;32(7):1306-1314. doi: 10.1021/acs.bioconjchem.0c00649. Epub 2021 Jan 21. PMID: 33475350; PMCID: PMC8292437.

Kang L, Li C, Rosenkrans ZT, Huo N, Chen Z, Ehlerding EB, Huo Y, Ferreira CA, Barnhart TE, Engle JW, Wang R, Jiang D, Xu X, Cai W. CD38-Targeted Theranostics of Lymphoma with 89Zr/177Lu-Labeled Daratumumab. Adv Sci (Weinh). 2021 Mar 15;8(10):2001879. doi: 10.1002/advs.202001879. PMID: 34026426; PMCID: PMC8132161.

Kang L, Li C, Rosenkrans ZT, Engle JW, Wang R, Jiang D, Xu X, Cai W. Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab')2 Fragments of Obinutuzumab in Lymphoma. J Nucl Med. 2021 Mar;62(3):372-378. doi: 10.2967/jnumed.120.246595. Epub 2020 Aug 21. PMID: 32826320; PMCID: PMC8049347.